Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 14 Similar Profiles
RNA-Binding Proteins
Medicine & Life Sciences
Messenger RNA
Medicine & Life Sciences
Glioblastoma
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Genes
Medicine & Life Sciences
RNA
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Gene Expression
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2009 2018
Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells
Penalva, L. O. & Nakano, I.
1/1/14 → 12/31/15
Project: Research project
Glioblastoma
Mesenchymal Stromal Cells
Glioma
Small Interfering RNA
Stem Cells
Computational Methods for Deep Sequencing Based RBP Binding Motif Characterizatio
Penalva, L. O. & Smith, A. D.
12/1/10 → 7/31/18
Project: Research project
High-Throughput Nucleotide Sequencing
RNA-Binding Proteins
Binding Sites
Computational methods
Colonic Neoplasms
Alternative splicing regulation in perspective: A global analysis of exon skippin
4/14/09 → 2/28/12
Project: Research project
Alternative Splicing
RNA-Binding Proteins
Exons
Genes
RNA
Research Output 1996 2018
1
Citation
(Scopus)
Increased expression of the thyroid hormone nuclear receptor TRa1 characterizes intestinal tumors with high Wnt activity
Uchuya-Castillo, J., Aznar, N., Frau, C., Martinez, P., Le Nevé, C., Marisa, L., Penalva, L. O., Laurent-Puig, P., Puisieux, A., Scoazec, J. Y., Samarut, J., Ansieau, S. & Plateroti, M., Jul 24 2018, In : Oncotarget. 9, 57, p. 30979-30996 18 p.Research output: Contribution to journal › Article
Thyroid Hormone Receptors
Wnt Signaling Pathway
Cytoplasmic and Nuclear Receptors
Colorectal Neoplasms
Intestinal Neoplasms
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells
Yi, C., Li, G., Ivanov, D. N., Wang, Z., Velasco, M. X., Hernández, G., Kaundal, S., Villarreal, J., Gupta, Y. K., Qiao, M., Hubert, C. G., Hart, M. J. & Penalva, L. O., Nov 2 2018, In : RNA Biology. 15, 11, p. 1420-1432 13 p.Research output: Contribution to journal › Article
Luteolin
Glioblastoma
RNA
Phenotype
Neoplasms
3
Citations
(Scopus)
Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity
Correa, B. R. S., Hu, J., Penalva, L. O., Schlegel, R., Rimm, D. L., Galante, P. A. F. & Agarwal, S., Dec 1 2018, In : Scientific Reports. 8, 1, 4097.Research output: Contribution to journal › Article
Genetic Heterogeneity
Neoplasms
Cell Biology
Exome
Translational Medical Research
From mechanisms to therapy: RNA processing’s impact on human genetics
Penalva, L. O. & Sanford, J. R., Sep 1 2017, In : Human Genetics. 136, 9, p. 1013-1014 2 p.Research output: Contribution to journal › Editorial
Medical Genetics
RNA
Therapeutics
8
Citations
(Scopus)
MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
Cirilo, P. D. R., de Sousa Andrade, L. N., Corrêa, B. R. S., Qiao, M., Furuya, T. K., Chammas, R. & Penalva, L. O., Nov 10 2017, In : BMC Cancer. 17, 1, 750.Research output: Contribution to journal › Article
MicroRNAs
Melanoma
temozolomide
prohibitin
Luciferases